Case Summary:

With a doctorate of pharmacy (PharmD) degree, a South-Korea based researcher intending to advance in the field of pharmaceutical science hired North America Immigration Law Group to file an EB-2 NIW (National Interest Waiver) petition on her behalf. After she contacted us, our associated team started scrutinizing her credentials. Following a thorough assessment, we accumulated an array of important details pertaining to her educational and professional successes. Thus, we listed the subsequent points that paved the way for her national interest waiver progress.

• Research Summary– Our client’s work focused on performing data analysis, interpretation, and modeling and simulation research in the specific area of clinical pharmacology and pharmacokinetic/pharmacodynamic and how it is of great importance. We concluded that her research is crucial because it lays the foundation of drug discovery and development. Therefore, her intended work represents great strides in pharmaceutical science, and her ongoing contributions are essential to ensuring U.S. superiority in this area.
• Publication & Citation Count– We also detailed her publication record of 4 peer-reviewed journal articles (1 of them first-authored), which had accumulated 27 citations from the other foremost researchers in the field. All of these are well-read and – cited in the field of pharmaceutical sciences, and the publication of her work has rendered outstanding exposure to her findings, which speaks volumes of her status as a leading expert in the pharmaceutical sciences field.
• Peer Review Experience– Not only did she have a noble record of achievement in publications and citations but she had already conducted 2 peer reviews for elite journals as a peer reviewer in the field. With her nuanced knowledge of the many facets of the pharmaceutical science field, she is certainly an invaluable asset to the U.S.

Furthermore, her research has also been supported by funding from top-leading agencies, and this funding includes grants from the PhRMA Foundation, the American Cancer Society, and the Division of Microbiology and Infectious Diseases of the National Institutes of Allergy and Infectious Diseases through the National Institutes of Health. These organizations focus on innovative scientific research to improve public health. Such funding demonstrates research of high importance, thus cementing the prominence of our client’s research.

• Testimonials– To encourage our client’s EB-2 petition further, we included five of her obtained recommendation letters from other well-noted researchers in the field. Below is the statement cited from one of the letters:

“[Client’s] research has practical implications throughout the field, and she has consistently made supportive research contributions. There are several notable examples of this influence, including the use of her work in novel developments in clinical trials conducted by the National Institutes of Health, proving that she is playing an active role in national public health research.”

Overall, we are delighted to help our client in achieving the NIW approval despite a long wait. Special thanks to our team for constantly supporting her, and we would like to thank her as well for trusting and coordinating with us throughout the process. We wish her the best as she continues to progress in her chosen field.